Center for Unmet, Rare, and Emerging Diseases

The Center for Unmet, Rare, and Emerging Diseases (CURED), formed by immunology and molecular medicine professor Andrew Dillin and announced in December 2025, unites researchers across UC Berkeley to pursue cures that other organizations are not pursuing. It focuses on cancer, rare diseases, autoimmune and inflammatory diseases, and infectious and emerging diseases of global concern, seeking mechanisms that apply across multiple diseases.

CURED draws on campus research centers including the Innovative Genomics Institute, the Molecular Therapeutics Initiative and the Stem Cell Center, and after a discovery connects researchers with the Bay Area's philanthropic, venture capital and biotech communities to move it toward clinical trials.